Ledger.Open graph →
SEC Form D · Amendment · filed August 3, 2023

CeleCor Therapeutics, Inc

Offering
$42.5M
Sold
$17.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Neil Graham, Mbbs, M.D., Mph · Singapore, U0DirectorMichael S. Falk · West Palm Beach, FLDirectorMatthew Kennedy · New York, NYExecBenjamin Fogle · West Des Moines, IADirectorAndreas B. Ritzi · Zug, V8DirectorAlexandre M. Kaoukhov · Singapore, U0Exec · DirectorPaul J. Newfield · Wellington, Q2DirectorJack B. Lief · Del Mar, CADirectorSteven W. Davis · Birmingham, ALExecPeter B. Finn · Boston, MAExecRobert Hillman · Del Mar, CAExec · DirectorRobert A. O'Sullivan · West Palm Beach, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗